BATISTUZZO J.A.de O
Romero-Gomez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RL, et al
Neuroinflammation 9 , 163 (2012)
Figure 2 The neuroprotective effects of GLP-1 receptor agonists (RAs) such as liraglutide and exendin-4 have been demonstrated in numerous clinical trials related to diabetic neurological complications, including stroke and cognitive impairment (7578)
Increased Energy Expenditure: GLP-1 RAs may activate sympathetic pathways in the hypothalamus (specifically the dorsomedial and ventromedial nuclei) that increase thermogenic activity in brown adipose tissue (BAT), contributing to increased energy expenditure and weight loss
Gim cc triu chng ca bnh Parkinson Bnh Parkinson nh hng n h thng thn kinh trung ng v c xc nh bi cc triu chng nh chng run chn tay